David Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David Cheng has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Aruna Kamineni
Kaiser Permanente Washington Health Research Institute , Seattle, WA
13 shared publications - Claudia L. Werner
Department of Obstetrics and Gynecology, University of Southwestern Medical Center, Dallas, Texas. 4
13 shared publications - Jacquelyn M. Lykken
Division of General Internal Medicine, Massachusetts General Hospital
13 shared publications - Jasmin A. Tiro
University of Chicago, Comprehensive Cancer Center, Chicago, IL
13 shared publications - Jennifer S. Haas
Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States
13 shared publications - Meghan L. Rieu-Werden
Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. 2
13 shared publications
Latest Publications
- Open Access
- 26 July 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 71 (5) , 108523
A Qualitative Comparative Analysis of State Flavored E-Cigarette Policy Implementation and E-Cigarette Use
- 26 July 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 71 (5) , 108523
Open AccessA Qualitative Comparative Analysis of State Flavored E-Cigarette Policy Implementation and E-Cigarette Use
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S2 shows the parameters used to define guideline-concordant management after the index abnormality and the initial colposcopy.
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S2 shows the parameters used to define guideline-concordant management after the index abnormality and the initial colposcopy.
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S4 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at PH.
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S4 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at PH.
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S2 shows the parameters used to define guideline-concordant management after the index abnormality and the initial colposcopy.
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S2 shows the parameters used to define guideline-concordant management after the index abnormality and the initial colposcopy.
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S3 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at MGB.
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S3 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at MGB.
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S1 shows the inclusion/exclusion criteria applied to determine the study sample and the sample size after applying each criteria to the overall and site-specific samples.
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S1 shows the inclusion/exclusion criteria applied to determine the study sample and the sample size after applying each criteria to the overall and site-specific samples.
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S3 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at MGB.
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S3 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at MGB.
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S5 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at KPWA.
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S5 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at KPWA.
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S1 shows the inclusion/exclusion criteria applied to determine the study sample and the sample size after applying each criteria to the overall and site-specific samples.
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S1 shows the inclusion/exclusion criteria applied to determine the study sample and the sample size after applying each criteria to the overall and site-specific samples.
- Open Access
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S5 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at KPWA.
- 1 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings
Supplementary Table S5 shows associations between patient characteristics and guideline-concordant follow-up after the index abnormality and the initial colposcopy based on multivariable logistic regression among patients at KPWA.